Results 71 to 80 of about 42,888 (218)

Philadelphia chromosome positive AML arising from JAK2-positive myelofibrosis

open access: yesBiomarker Research, 2018
Background A feature of myeloproliferative neoplasia is transforming to more aggressive and malignant myeloid neoplasia, including acute myeloid leukemia.
Marte Karen Brattås   +8 more
doaj   +1 more source

A computational dynamic model of combination treatment for type II inhibitors with asciminib

open access: yesProtein Science, Volume 34, Issue 8, August 2025.
Abstract Despite continuous strides forward in drug development, resistance to treatment looms large in the battle against cancer as well as communicable diseases. Chronic myeloid leukemia (CML) is treated with targeted therapy and treatment is personalized when resistance arises.
J. Roadnight Sheehan   +2 more
wiley   +1 more source

Umbilical cord blood transplantation from unrelated donors in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia

open access: yesHaematologica, 2014
There are very few disease-specific studies focusing on outcomes of umbilical cord blood transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia.
José Luis Piñana   +15 more
doaj   +1 more source

Genetic Architecture of Immune Cell DNA Methylation in the Rhesus Macaque

open access: yesMolecular Ecology, Volume 34, Issue 15, August 2025.
ABSTRACT Genetic variation that impacts gene regulation, rather than protein function, can have strong effects on trait variation both within and between species. Epigenetic mechanisms, such as DNA methylation, are often an important intermediate link between genotype and phenotype, yet genetic effects on DNA methylation remain understudied in natural ...
Christina E. Costa   +12 more
wiley   +1 more source

Molecular characterization and predictors of relapse in patients with Ph + ALL after frontline ponatinib and blinatumomab

open access: yesJournal of Hematology & Oncology
Background Several studies have suggested that chemotherapy-free regimens consisting of blinatumomab and a BCR::ABL1 tyrosine kinase inhibitor are highly effective in Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph + ALL).
Nicholas J. Short   +12 more
doaj   +1 more source

Cancer treatment and survivorship statistics, 2025

open access: yesCA: A Cancer Journal for Clinicians, Volume 75, Issue 4, Page 308-340, July/August 2025.
Abstract The number of people living with a history of cancer in the United States continues to rise because of the growth and aging of the population as well as improved survival through advances in early detection and treatment. To assist the public health community serve the needs of these survivors, the American Cancer Society and the National ...
Nikita Sandeep Wagle   +9 more
wiley   +1 more source

Discovery of the Philadelphia chromosome: a personal perspective [PDF]

open access: yesJournal of Clinical Investigation, 2007
Almost 50 years ago, David Hungerford and I noticed an abnormally small chromosome in cells from patients with chronic myelogenous leukemia (CML). This article is a personal perspective of the events leading to the discovery of this chromosome, which became known as the Philadelphia chromosome.
openaire   +3 more sources

Philadelphia-chromosome-positive pre-B-cell leukemia presenting as blast crisis of chronic myelogenous leukemia [PDF]

open access: bronze, 1979
LB Vogler   +5 more
openalex   +1 more source

Home - About - Disclaimer - Privacy